Paul Eze
Impact in
- Infectious Diseases top 10%
- Clostridium difficile and Clostridium perfringens research
- Health top 10%
- Vaccine Coverage and Hesitancy
Papers in
- Co-authors
- Lucky Osaheni Lawani (15 shared papers)Nair Harish (1 shared paper)Evelyn Balsells (1 shared paper)Moe H. Kyaw (1 shared paper)Yubraj Acharya (5 shared papers)Oghenekaro Omodior (2 shared papers)Chidozie U Nduka (1 shared paper)Kenechukwu N. Mezue (1 shared paper)
- Journals
- PLoS ONE (3 papers)Ticks and Tick-borne Diseases (2 papers)BMJ Open (1 paper)BMC Pregnancy and Childbirth (1 paper)INQUIRY The Journal of Health Care Organization Provision and Financing (1 paper)
- Partner nations
- United StatesNigeriaCanada
In The Last Decade
Paul Eze
22 papers receiving 399 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 159
- Health 64
- Critical Care and Intensive Care Medicine 24
- Finance 45
- Parasitology 21
Countries citing papers authored by Paul Eze
This map shows the geographic impact of Paul Eze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Eze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Eze more than expected).
Fields of papers citing papers by Paul Eze
This network shows the impact of papers produced by Paul Eze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Eze. The network helps show where Paul Eze may publish in the future.
Co-authors
The 22 scholars most cited alongside Paul Eze, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 134 | |
| 2 | 2021 | 38 | |
| 3 | 2021 | 38 | |
| 4 | 2022 | 37 | |
| 5 | 2023 | 32 | |
| 6 | Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials. | 2021 | 19 |
| 7 | 2020 | 16 | |
| 8 | 2024 | 13 | |
| 9 | 2020 | 13 | |
| 10 | 2021 | 12 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2023 | 6 | |
| 16 | Public Debt Spiral and Domestic Investment in Nigeria | 2018 | 5 |
| 17 | 2020 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2022 | 3 |
About Paul Eze
Paul Eze is a scholar working on Finance, Health, Parasitology, Infectious Diseases and General Health Professions, having authored 24 papers that have together received 411 indexed citations. Recurring topics across this work include Healthcare Systems and Reforms (5 papers), Vaccine Coverage and Hesitancy (4 papers), Global Maternal and Child Health (2 papers), Vector-borne infectious diseases (2 papers), Global Health Care Issues (2 papers), Plant responses to elevated CO2 (1 paper), Urban Green Space and Health (1 paper) and Health Sciences Research and Education (1 paper). The work is most often cited by research in Infectious Diseases (159 citations), Health (64 citations), Critical Care and Intensive Care Medicine (24 citations), Finance (45 citations) and Parasitology (21 citations). Paul Eze has collaborated with scholars based in United States, Nigeria and Canada. Frequent co-authors include Lucky Osaheni Lawani, Nair Harish, Evelyn Balsells, Moe H. Kyaw, Yubraj Acharya, Oghenekaro Omodior, Chidozie U Nduka, Kenechukwu N. Mezue, Chukwuemeka Anthony Iyoke and Ozoemena Stanley Nwodo. Their work appears in journals such as PLoS ONE, Ticks and Tick-borne Diseases, BMJ Open, BMC Pregnancy and Childbirth and INQUIRY The Journal of Health Care Organization Provision and Financing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.